[ad_1]
According to SAM, Lithuania’s decision to buy this medicine was determined by the fact that last week the European Commission (EC), taking into account on June 25, 2020 The European Medicines Agency (EMA) has recommended the approval of Remdesivir for the treatment of COVID-19 as recommended by the Committee for Medicinal Products for Human Use.
Remdesivir is recommended for the treatment of coronavirus infection in adults and adolescents from 12 years of age who develop pneumonia and therefore require supplemental oxygen. The commercial name of remdesivir is Veklury.
Remdesivir is given as an infusion (drip) into a vein. It was originally developed to treat an illness caused by the Ebola virus.
According to SAM, remdesivir is the first medicine recommended by the Committee for Medicinal Products for Human Use to be authorized in the EU. The efficacy and safety data for remdesivir were evaluated exceptionally quickly using the ongoing review procedure, which is specifically designed for emergencies where the data is evaluated only when available. The Committee began evaluating the information on the efficacy and safety of the medicine starting this year. meter. April 30th
[ad_2]
